Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Diastolic dysfunction refers to abnormal mechanical properties of the myocardium and includes abnormal LV diastolic distensibility, impaired filling and slow or delayed relaxation- regardless of whether the ejection fraction is normal or depressed and whether the patient is asymptomatic or symptomatic. Epidemiologic studies have demonstrated high prevalence of diastolic heart failure (DHF). The quality of life of these patients is impaired and the clinical outcomes are similar to those with heart failure with systolic dysfunction. Therefore diastolic dysfunction has significant adverse economic impact that is expected to grow further with time. Clinical characteristics alone may not be sufficient to diagnose diastolic dysfunction. A number of invasive and non-invasive parameters have been proposed to diagnose diastolic dysfunction. Most of the presently used non-invasive parameters have a number of limitations. High fidelity measurement of the left ventricular pressures is needed to accurately diagnose diastolic dysfunction. Obtaining it in routine clinical practice is impractical.
In this protocol the investigators have proposed a novel non-invasive parameter called 'Torsional Hysteresis' as a measure of diastolic function. This will be measured using non-invasive cardiac MRI technique. During left ventricular contraction and relaxation, myocardium deforms. During cardiac cycle the myocardium goes back to baseline state prior to beginning of each contraction. However the rate with which it returns to the baseline state is variable. Torsion indicates relative wringing motion of the ventricle around a left ventricular axis and is a global parameter of left ventricular deformation. The parameters have defined a new parameter called torsional hysteresis based on non invasive cardiac MRI assessment. The parameters have hypothesized that for diastolic dysfunction, the torsional hysteresis area is increased as compared to no diastolic dysfunction group.
| Condition |
|---|
|
Heart Failure Diastolic Heart Failure Heart Failure With Normal Ejection Fraction |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function |
- To show that torsional hysteresis relates to invasive hemodynamic measure of diastolic function [ Time Frame: one time at enrollment ] [ Designated as safety issue: No ]To show that torsional hysteresis relates to invasive hemodynamic measure of diastolic function: a) Exponential fall of pressure during isovolumic relaxation phase by the time constant of relaxation, tau and b) LV end diastolic pressure-volume relationship (EDPVR).
- To demonstrate that torsional hysteresis is a relatively load independent measure of global diastolic function [ Time Frame: one time at enrollment ] [ Designated as safety issue: No ]To demonstrate that torsional hysteresis is a relatively load independent measure of global diastolic function by evaluating effects of nitroglycerin (NTG) on torsional hysteresis and correlating it to invasive hemodynamic measure of diastolic function including a) tau and b) EDPVR.
- To evaluate the sensitivity and specificity of torsional hysteresis in diagnosing diastolic dysfunction [ Time Frame: one time at enrollment ] [ Designated as safety issue: No ]To evaluate the sensitivity and specificity of torsional hysteresis in diagnosing diastolic dysfunction (as defined by invasive hemodynamic parameters: tau, EDPVR) and compare it to echocardiographic tissue Doppler assessment in patients undergoing cardiac catheterization for suspected diastolic dysfunction
| Estimated Enrollment: | 180 |
| Study Start Date: | August 2011 |
| Estimated Study Completion Date: | June 2015 |
| Estimated Primary Completion Date: | June 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Diastolic Function
Patients scheduled for cardiac catheterization.
|
Eligibility| Ages Eligible for Study: | 19 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients scheduled for cardiac catheterization.
Inclusion Criteria:
Major inclusion criteria: Normal screening LV ejection fraction.
Exclusion Criteria:
- Atrial fibrillation or other significant cardiac arrhythmia on ECG
- Presence of pacemaker or defibrillator
- Angioplasty or primary coronary intervention PCI/PTCA during index cardiac catheterization.
- Patient is unable to undergo cardiac MRI due to contraindication to MRI (MRI incompatible metal prosthesis or implants or significant claustrophobia).
- Patient taking phosphodiesterase 5 inhibitor (eg. sildenafil) will be excluded due to potential interaction with nitroglycerin.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Himanshu Gupta, Associate Professor, University of Alabama at Birmingham |
| ClinicalTrials.gov Identifier: | NCT01431027 History of Changes |
| Other Study ID Numbers: | F101215002, 5R01HL104018 |
| Study First Received: | August 3, 2011 |
| Last Updated: | January 14, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Alabama at Birmingham:
|
Heart Failure Diastolic Heart Failure Heart Failure with Normal Ejection Fraction |
Additional relevant MeSH terms:
|
Heart Failure Heart Failure, Diastolic Heart Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 23, 2013